Non-surgical knee treatment Queen Creek: what can ease the soreness

What to try before surgery

Years of use can leave the joint sore, stiff, or swollen. An old injury may also start bothering you again.

Gentle movement often helps more than sitting from morning through supper. Try shorter walks, steady leg work, and a cane for safer footing.

Heat may loosen the knee before activity, while cold may calm swelling afterward. Gel or anti-inflammatory tablets may help, but ask whether they fit your medicines.

QC Kinetix can examine the knee when home care no longer helps. Its regenerative treatments are clinic procedures done by medical providers with blood taken from you.

Platelet-rich plasma, or PRP, is the platelet-heavy portion of a spun blood sample. A provider puts it into the sore joint and may discuss concentrated PRP.

The hoped-for result is calmer soreness and more comfortable daily movement. Results differ, and a visit may show that a surgeon's view is more useful.

When to have the knee checked

Arrange an exam if soreness returns often or shortens your walks. Take your medicines and explain when the soreness started.

The exam checks swelling, strength, motion, and the way you walk. An X-ray may help, but your account and the exam come first.

A hot, red knee needs same-day care, not a routine visit. After a fall, seek help quickly if you can't stand on that leg.

What to ask when surgery comes up

A knee replacement can help after serious damage has narrowed daily life. It is a major operation, so timing deserves a direct talk.

Ask whether steady exercise and medicine have had a fair chance. Ask what waiting could mean for walking, sleep, and getting dressed.

Some people can wait while those daily tasks remain steady. If they keep getting harder, repeating the same care may only extend the soreness.

Sources

1. A 2021 JAMA review states that osteoarthritis affects an estimated 240 million people worldwide including more than 32 million in the US, that 33% of people older than 75 have symptomatic and radiographic knee OA, that diagnosis is clinical despite widespread overuse of imaging, that people with OA are more sedentary and carry a 20% higher age-adjusted mortality, and that the cornerstones of management are exercise, weight loss where appropriate and education, complemented by topical or oral NSAIDs, with opiates to be avoided.

   Katz JN, Arant KR, Loeser RF. — Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review.. JAMA, 2021. DOI: 10.1001/jama.2020.22171.

2. The Cochrane review of land-based therapeutic exercise for knee osteoarthritis extracted data from 54 randomised trials, assessing pain, physical function and quality of life immediately after treatment and the sustained effect at 2-6 months and beyond 6 months. Only 19 of the included studies (20%) met all three low-risk-of-bias criteria the authors applied.

   Fransen M, McConnell S, Harmer AR, et al. — Exercise for osteoarthritis of the knee.. Cochrane Database of Systematic Reviews, 2015. DOI: 10.1002/14651858.CD004376.pub3.

3. The Cochrane review of land-based therapeutic exercise for HIP osteoarthritis included 10 randomised trials, seven of which the authors judged to have a low risk of bias, though results remain vulnerable to performance and detection bias because participants could not be blinded and all primary outcomes were self-reported. The evidence base for hip is substantially thinner than for knee.

   Fransen M, McConnell S, Hernandez-Molina G, et al. — Exercise for osteoarthritis of the hip.. Cochrane Database of Systematic Reviews, 2014. DOI: 10.1002/14651858.CD007912.pub2.

4. The 2019 ACR/Arthritis Foundation guideline makes STRONG recommendations for exercise, weight loss in people with knee and/or hip OA who are overweight or obese, self-efficacy and self-management programs, tai chi, cane use, tibiofemoral bracing for tibiofemoral knee OA, topical NSAIDs for knee OA, oral NSAIDs, and intra-articular glucocorticoid injections for knee OA. Radiofrequency ablation for knee OA, acupuncture, thermal modalities, acetaminophen, duloxetine and tramadol are only CONDITIONAL recommendations.

   Kolasinski SL, Neogi T, Hochberg MC, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee.. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41142.

5. In the only randomised controlled trial to compare total knee replacement directly with non-surgical treatment in patients already eligible for surgery (n=100), the replacement group improved more at 12 months than the non-surgical group (KOOS4 32.5 vs 16.0; adjusted mean difference 15.8, 95% CI 10.0 to 21.5) but had four times the serious adverse events (24 vs 6, P=0.005). Only 13 of 50 patients (26%) assigned to non-surgical treatment alone had undergone knee replacement by 12 months.

   Skou ST, Roos EM, Laursen MB, et al. — A Randomized, Controlled Trial of Total Knee Replacement.. New England Journal of Medicine, 2015. DOI: 10.1056/NEJMoa1505467.

6. Pooling the OAI and MOST cohorts (8,002 participants followed up to 8 years, 3,417 classifiable knees), validated appropriateness criteria classified only 290 knees (8%) as receiving a TIMELY total knee replacement, 2,833 knees (83%) as potentially appropriate but not replaced more than 2 years after replacement became appropriate, and 294 knees (9% of all knees, 26% of the 1,114 replacements actually performed) as PREMATURE. Of the potentially-appropriate-but-not-replaced knees, 1,204 (42.5%) had severe symptoms.

   Ghomrawi HMK, Mushlin AI, Kang R, et al. — Examining Timeliness of Total Knee Replacement Among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts.. Journal of Bone and Joint Surgery (American), 2020. DOI: 10.2106/JBJS.19.00432.

7. FDA states directly that regenerative medicine therapies - including stem cells, stromal vascular fraction, umbilical cord blood, amniotic fluid, Wharton's jelly, ortho-biologics and exosomes - have NOT been approved for the treatment of any orthopedic condition, naming osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain. FDA further states that being charged for these products, or being offered them outside an FDA-overseen clinical trial, means a patient is likely being deceived and offered a product illegally, and that a product's presence on clinicaltrials.gov or a firm's FDA registration does not mean the product is legally marketed. Reported harms include blindness, tumor formation, neurological events and life-threatening bacterial infections.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Important Patient and Consumer Information About Regenerative Medicine Therapies. FDA.gov, 2021.